Merrill Goozner
Editor and Publisher at GoozNews
Editor Emeritus at Modern Healthcare
Freelance writer & Editor-Publisher of GoozNews
Articles
-
6 days ago |
gooznews.substack.com | Merrill Goozner |Carl Elliott
Washington is awash in legal and ethical wrongdoing, especially at the nation’s health-related agencies. To pay for tax cuts for corporations and the rich, the Trump regime’s appointees are laying off thousands of workers at the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health. Aid to treat and prevent global diseases has been abandoned. Plans are afoot to slash funding for the nation’s researchers.
-
1 week ago |
nationalmemo.com | Merrill Goozner
By appointing Dr. Vinay Prasad to run the Center for Biologics Evaluation and Research, the Trump regime has installed another prominent opponent of Covid-era public health policies to a key position at the Food and Drug Administration. CBER is responsible for ensuring the safety and efficacy of vaccines, biologic drugs, gene therapies and the blood supply.
-
1 week ago |
gooznews.substack.com | Merrill Goozner
By appointing Dr. Vinay Prasad to run the Center for Biologics Evaluation and Research, the Trump regime has installed another prominent opponent of Covid-era public health policies to a key position at the Food and Drug Administration. CBER is responsible for ensuring the safety and efficacy of vaccines, biologic drugs, gene therapies and the blood supply.
-
1 week ago |
nationalmemo.com | Merrill Goozner
In 1999, 18-year-old Jesse Gelsinger eagerly signed up for a clinical trial testing a promising therapy for his rare genetic disorder. The Arizona resident’s dream was to lead a normal life that wouldn’t require him swallowing four dozen pills a day simply to stay alive. He traveled to the University of Pennsylvania where physician-scientists were conducting an early experiment in gene therapy. They told Gelsinger they would implant a working gene for his mutated one using a viral vector.
-
2 weeks ago |
gooznews.substack.com | Merrill Goozner
In 1999, 18-year-old Jesse Gelsinger eagerly signed up for a clinical trial testing a promising therapy for his rare genetic disorder. The Arizona resident’s dream was to lead a normal life that wouldn’t require him swallowing four dozen pills a day simply to stay alive. He traveled to the University of Pennsylvania where physician-scientists were conducting an early experiment in gene therapy. They told Gelsinger they would implant a working gene for his mutated one using a viral vector.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 3K
- DMs Open
- No
RFK Jr. visited Indiana today to tout its Make America Healthy Again agenda, better described as Die now, eat healthier later. See my latest: @_GoozNews https://t.co/i65imM45lm
I've just joined the podcast world. My first interview is with Dr. Farzad Mostashari @Farzad_MD @AledadeACO. Does value-based care have a future? @_GoozNews https://t.co/vCRhqOO2Mp
An incisive critique of the abundance agenda: Why only a powerful, effective government can challenge corporate/oligarch power and bring the renewal America needs. https://t.co/BrgVm4Cr4L